Market Place
Sourcing Support
Novo Nordisk A/S - Share Repurchase Programme
16 Feb 2026 //
GLOBENEWSWIRE
Oral Wegovy Brings In Thousands Of New GLP-1 Patients
12 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
11 Feb 2026 //
GLOBENEWSWIRE
Novo, Lilly Earnings Ignite Weight Loss Drama, Gene Therapy Buzz
11 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
10 Feb 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
FDA Untitled Letters Target Drug Ads From Novo, Argenx, Sobi
10 Feb 2026 //
FIERCE PHARMA
Hims & Hers’ Woes Compound as FDA Hit Company With Warning Letter
10 Feb 2026 //
BIOSPACE
Novo Nordisk Sues Hims & Hers Over Counterfeit Wegovy®
09 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
09 Feb 2026 //
GLOBENEWSWIRE
Hims Quits On Obesity Pill After Legal, Regulatory Heat
09 Feb 2026 //
FIERCE PHARMA
Makary Criticizes `Illegal Copycat Drugs` Amid Hims` Compounded
06 Feb 2026 //
BIOSPACE
Amylin`s Oral Obesity Assets Gain Momentum In 2026
06 Feb 2026 //
BIOSPACE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Novo`s 1St Super Bowl Ad Taps Celebs To Tout Wegovy Pill
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Launches Wegovy® Pill For Consumers At Major Event
06 Feb 2026 //
PR NEWSWIRE
US Government Launches Trumprx Drug Purchasing Portal
06 Feb 2026 //
FIERCE PHARMA
FDA Commissioner Pledges Crackdown On Compounding Practices
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Fires Back at Hims` $49 Semaglutide Pill
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Flags Concerns Over Pharmazee GLP-1 Scripts
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Board, Executives, and Associates Trade Shares
05 Feb 2026 //
GLOBENEWSWIRE
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Addresses Hims & Hers` Illegal Compounding
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Files Annual Report With The SEC
04 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk`s Sales Rise 10% To DKK 309.1B In 2025
03 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Releases 2026 Sales And Operating Profit Outlook
03 Feb 2026 //
GLOBENEWSWIRE
Novo Slides 14% On Early Q4 Results Forecasting 2026 Sales Drop
03 Feb 2026 //
BIOSPACE
Novo`s next-gen obesity drug outperforms Wegovy in diabetes trial
02 Feb 2026 //
REUTERS
Obesity Market Sales Tightens as Novo & Lilly Enter New Era
02 Feb 2026 //
REUTERS
Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study
02 Feb 2026 //
FIERCE BIOTECH
Novo Nordisk A/S Appoints New Board Member
31 Jan 2026 //
GLOBENEWSWIRE
Betterway Introduces GLP-1 Blood Test Panel At Austin, Temple
29 Jan 2026 //
PHARMIWEB
Novo Wins Support From Big Business In Its Ongoing IRA Challenge
29 Jan 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera
27 Jan 2026 //
FIERCE BIOTECH
Wegovy Pill Launch Wows With Strong Early Uptake: Analysts
23 Jan 2026 //
FIERCE PHARMA
Novo`s Wegovy pill hits over 18,000 US prescriptions in Debut
23 Jan 2026 //
REUTERS
New Consortium Transforms Antibiotic Discovery to Counter AMR
22 Jan 2026 //
PR NEWSWIRE
Sesame Launches Wegovy Pill Through Collaboration With Novo
22 Jan 2026 //
BUSINESSWIRE
Novo Expands Diabetes Cell Therapy Partnership with Aspect Bio
21 Jan 2026 //
REUTERS
Novo Riffs On Apple`s `Get A Mac` Ads In New Ozempic Push
20 Jan 2026 //
FIERCE PHARMA
Novo Nordisk Launches "There`s Only One Ozempic" Campaign
20 Jan 2026 //
PR NEWSWIRE
CDMOs Pin Hopes on FDA PreCheck for New U.S. Sites
20 Jan 2026 //
BIOSPACE
Novo Holdings Buys 49% Stake In Surya Hospitals
20 Jan 2026 //
ECONOMICTIMES
Aspect Biosystems, Novo Nordisk Advance Partnership For Diabetes
20 Jan 2026 //
GLOBENEWSWIRE
SEC Recommends Three Firms For Semaglutide Formulations
19 Jan 2026 //
PHARMABIZ
Novo Boosted As Oral Wegovy Reaches 3,000 Patients In Debut Week
19 Jan 2026 //
BIOSPACE
JPM26: All Of The Meetings, None Of The Megadeals
15 Jan 2026 //
FIERCE BIOTECH
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
15 Jan 2026 //
BIOSPACE
Novo Foundation Invests $860M To Nurture Homegrown Biotechs
15 Jan 2026 //
FIERCE BIOTECH
Novo Refocuses On Diabetes & Obesity, Expanding GLP-1 Market
14 Jan 2026 //
BIOSPACE
Lilly Strategizes For Dominance In Evolving Obesity Market
14 Jan 2026 //
BIOSPACE
Strive Pharmacy Sues Eli Lilly and Novo Nordisk
14 Jan 2026 //
PR NEWSWIRE
JPM26: Novo CEO Outlines R&D, Marketing Tactics For 2026
14 Jan 2026 //
FIERCE PHARMA
Pfizer Expedites Obesity Programs Amid Patent Cliff Challenge
13 Jan 2026 //
BIOSPACE
JPM: Novo CSO Craves `Different Flavors` Of Pipeline Innovation
13 Jan 2026 //
FIERCE BIOTECH
JPM26 Day 1: Obesity Front-And-Center, Q4 Sales Beats
13 Jan 2026 //
BIOSPACE
US FDA Requests Removal of Suicide Warnings From Weight-loss Drug
13 Jan 2026 //
REUTERS
Ro.Co Analyzes 2026 FDA Launch Of Wegovy Pill Vs Shot
12 Jan 2026 //
GLOBENEWSWIRE
Canadian Pharma Platform To Provide Indian-Sourced Ozempic
09 Jan 2026 //
ECONOMICTIMES
